THYROCARE TECH LTD Financial Ratios
THYROCARE · Healthcare · Current price ₹577.2
P/E ratio
56.4x
P/B ratio
15.8x
ROE
28.4%
ROCE
35.0%
Debt / Equity
0.09
Dividend yield
2.4%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 56.4x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 15.8x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 28.4% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 35.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.09 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with THYROCARE TECH LTD's latest numbers.
THYROCARE TECH LTD profitability
THYROCARE TECH LTD generates a return on equity of 28.4% and a return on capital employed of 35.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.09 and a P/E of 56.4x, THYROCARE TECH LTD is conservatively financed. Our overall business-quality score for the company is 6.7 / 10.
Understand the ratios
More on THYROCARE TECH LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.